3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
21
Neoplasms
6
Neoplasm Metastasis
5
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Hereditary Sensory and Autonomic Neuropathies
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Breast Diseases
2
von Hippel-Lindau Disease
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors Refractory to Standard Therapy
1
Solid Tumor, Adult
1
Solid Tumor
1
Sarcoma
1
Recurrence
1
Rare Tumor
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasm, Residual
1
Melanoma
1
Medulloblastoma
1
Malignant Female Reproductive System Neoplasm
1
Lung Neoplasms
1
Interventions
palbociclib
1
microcrystalline cellulose
1
epigallocatechin gallate
1
dapagliflozin
1
Vitamin D
1
Tablets
1
Specimen Handling
1
Selenium
1
Saline Solution
1
Pregabalin
1
Platelet Count
1
Plastic Surgery Procedures
1
Omeprazole
1
Losartan
1
Ketorolac
1
Infliximab
1
Immunotherapy, Adoptive
1
Dexmedetomidine
1
Cognitive Behavioral Therapy
1
Calcium
1
Bevacizumab
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Inflammation
×
palbociclib
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled